Professional Documents
Culture Documents
Convulsions
Sheldon M. Wolf, Alan Forsythe, Alastair A. Stunden, Robert Friedman and Harriet
Diamond
Pediatrics 1981;68;820-823
The online version of this article, along with updated information and services, is located on
the World Wide Web at:
http://www.pediatrics.org
PEDIATRICS is the official journal of the American Academy of Pediatrics. A monthly publication, it
has been published continuously since 1948. PEDIATRICS is owned, published, and trademarked by the
American Academy of Pediatrics, 141 Northwest Point Boulevard, Elk Grove Village, Illinois, 60007.
Copyright © 1981 by the American Academy of Pediatrics. All rights reserved. Print ISSN: 0031-4005.
Online ISSN: 1098-4275.
ABSTRACT. Psychometric tests were performed on 50 reported previously.4 Children receiving phenobar-
children with a history of febrile convulsions. Twenty- bital began with a daily dose of 3-4 mg/kg. This
five of these had received daily phenobarbital for a mean
dosage was adjusted to attempt to maintain a
of 35 months; 25 had received no phenobarbital. The two
groups were matched for sex, age at the time of testing,
phenobarbital level of 10 to 15 jig/mi. In the chil-
race, and socioeconomic status. The tests used were the then receiving phenobarbital, the initial psycholog-
Wechsler Preschool and Primary Scale of Intelligence ical testing was done just prior to the planned
(WPPSI), the Matching Familiar Figures Test, and the termination of drug treatment. Parents were then
Children’s Embedded Figures Test. There were no signif-
instructed to taper the drug gradually over a period
icant differences in test results between the two groups.
Pediatrics 68:820-823, 1981; phenobarbital, cognitive of one to two months. The interval between the
I unction, convulsions. initial testing and retesting ranged from 1 1 to 19
weeks. The modal period between test administra-
tions was 12 weeks (46 subjects) with the mean
period being 13 weeks. Four children in the drug-
Daily phenobarbital therapy is effective in pre- treated group had only one set of psychological
venting recurrent febrile convulsions. 1-5 However, tests; these were given while the children were
adverse effects of phenobarbital on behavior, mem- receiving barbiturate therapy. Phenobarbital ther-
ory, attention, and performance on psychometric apy had not completely stopped in two children at
tests have been reported.’2 A major concern is the time of the second test. There were 26 girls and
whether phenobarbital given for several years to 24 boys; 32 children were white, eight were black,
prevent recurrent febrile convulsions may affect the and ten fell into other categories. The mean age at
intellectual development of children. the time of the initial testing was 57.5 months for
In this study of children with febrile convulsions, phenobarbital-treated children (SD 8.1 months,
we compared the performance, in several psycho- range 45 to 71 months) and 59.6 months for children
logical tests, of children who had received daily not receiving phenobarbital (SD 7.8 months, range
phenobarbital prophylaxis with those who had re- 48 to 73 months).
ceived no anticonvulsants. A psychologist (H.D.) with special training in the
testing of young children tested all subjects. We
METHODS attempted to test every English-speaking child who
had completed a course of phenobarbital. As this
The details of drug dosage and of selection and
part of the study was conceived and begun several
randomization of children into groups given pheno-
years after the main portion, only a minority of
barbital daily or not given phenobarbital have been
children treated with phenobarbital could be tested.
At no time did anyone other than the chief inves-
Received for publication Oct 27, 1980; accepted Feb 25, 1981. tigator know the group to which the child belonged.
Reprint requests to (5MW.) 1526 N Edgemont St, Los Angeles,
Every ninth test session was audiotaped to permit
CA 90027.
PEDIATRICS (ISSN 0031 4005). Copyright © 1981 by the
evaluation of the uniformity of test administration.
American Academy of Pediatrics. Typically a testing session lasted 2#{189}
hours with a
ARTICLES 821
Downloaded from www.pediatrics.org. Provided by Indonesia:AAP Sponsored on April 8, 2011
formed. Of these 73% were >10 tg/mi, and 45% phenobarbital. However, species difference, as well
were >15 Lg/mi; 84% of the children had levels >10 as the very high dosage and levels of drug involved,
zg/ml more than 50% of the time, and 86% had sharply limit the validity of extrapolating this data
>50% of the levels greater than 10 ig/m1 during the to children receiving clinically used dosages of
last year of phenobarbital treatment when the tests phenobarbital.
were given. Behavioral abnormalities in children with febrile
seizures receiving daily phenobarbital are common.
Although no evidence of adverse effect on cognitive
Psychological Test Results
function in children receiving daily phenobarbital
1. Initial testing during phenobarbital treatment was observed in the studies of Ellenberg and Ne!-
(Table 1) indicated no significant differences be- son’5 or Wallace,’6 blood levels were not monitored,
tween the two groups on any of the six psychological and it cannot be assumed that the drug was actually
test measurements when considered separately or being taken.
multivariately. Several studies in epileptic adults and children
2. In the retesting, three months after treatment have shown impairment of either psychomotor per-
stopped (Table 2), again there were no significant formance or short-term memory.9”7 Other studies’82#{176}
differences observed between the treatment and no- have not found any impairment of cognitive func-
treatment groups. tion associated with phenobarbital, but serum levels
3. There was no significant difference in degree were not measured. Hirtz2’ has pointed out that
of change of test scores from the initial to the later these studies in epileptics are often difficult to
tests when the two groups were compared. evaluate because of variability in etiology and type
The comparison of the more compliant with the of seizure disorder, degree of seizure control, age of
less compliant groups did not yield any significant the patients, drug levels, and usage of multiple
differences. The multivariate tests had P values drugs.
greater than 0.55, and the individual t tests on the The only study systematically testing cognitive
six test scores all had values greater
P than 0.19. function in children with febrile convulsions treated
with daily phenobarbital was reported by Camfield
et al.7 In this study, children with simple febrile
DISCUSSION
seizures who had completed either eight or 12
Animal studies’3”4 have shown deleterious effects months of therapy with phenobarbital or a placebo
on brain weight and chemical composition due to were tested with either the Bayley scale (if the child
With No Means±SEM t P
Pheno- Pheno-
barbital barbital
Verbal IQ 101.4 102.7 -1.26 ± 4.30 -0.29 .77
Performance IQ 115.2 113.7 1.43 ± 4.27 0.34 .74
Full-scale IQ 109.0 108.9 0.087 ± 4.44 0.02 .98
Children’s Embedded Figures 7.83 7.17 0.652 ± 1.01 0.64 .52
Matching Familiar Figures (time) 5.81 4.95 0.852 ± 0.727 1.17 .25
Matching Familiar Figures (errors) 2.32 2.16 0.153 ± 0.157 0.97 .34
0 Multivariate results: Hotelling T2 = 15.24; P = .128.
bital therapy had significantly lower “general com- 7. Camfield C, Chaplin 5, Doyle A, et al: Side effects of pheno-
prehension” scores than those tested after eight barbital in toddlers: Behavioral and cognitive aspects. J
Pediatr 95:361, 1979
months of treatment. The authors suggested that 8. Heckmatt J, Houston A, Dodds K, et al: Failure of pheno-
the longer exposure to phenobarbital might have barbitone to prevent febrile convulsions. Br Med J 1:559,
reduced general comprehension scores. Fishman,22 1976
9. MacLeod C, Dekaban A, Hunt E, et a!: Memory impairment
in an editorial critique of this paper, stated that the in epileptic patients: Selective effects of phenobarbit.al con-
Binet test does not yield meaningful test scores in centration..Scien.ce 202:1102, 1978
individual subcategories and considered that any 10. Hutt S, Jackson P, Beisham A, et al: Perceptual-motor
behavior in relation to blood phenobarbitone level: A prelim-
separate evaluation or correlation of Binet subtests inary report. Dev Med Child Neurol 10:626, 1968
was not justified. 11. Schain R, Ward J, Guthrie D: Carbamazepine as an anticon-
In our study, no impairment of cognitive function vulsant in children. Neurology 27:476, 1977
12. Knudsen F, Vestermark 5: Prophylactic diazepam or phen-
was observed in children receiving daily phenobar- obarbitone in febrile convulsions: A prospective controlled
bital for several years for the prevention of recur- study. Arch Dis Child 53:660, 1978
13. Schain R, Watanabe K: Origin of brain growth retardation
rent febrile convulsions. The comparison of the
in young rats treated with phenobarbital. Exp Neurol 50:
subgroups defined by compliance did not indicate 806, 1976
a dose-response relationship of cognitive test scores 14. Yanai J, Rosselli-Austin L, Tabakoff B: Neuronal deficits in
with serum phenobarbital levels, in this small series. mice following prenatal exposure to phenobarbital. Exp Neu-
rol 64:237, 1979
15. Ellenberg J, Nelson K: Febrile seizures and later intellectual
ACKNOWLEDGMENTS performance. Arch Neurol 35:17, 1978
ARTICLES 823